The Defense Logistics Agency awarded a $540,180 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The single award was issued against an unidentified indefinite-delivery/indefinite-quantity contract vehicle to supply 60 units of the ophthalmic solution. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 17-18, 2023. As a major distributor of pharmaceuticals and medical...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $1,800.80 to Amerisourcebergen Drug Corporation for the supply of 30 units of 0.05% RESTASIS eye emulsion. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility from August 22 to August 23, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for a specific eye medication supports DLA's mission to provide logistics support for...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,173 to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA customers. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with delivery required by September 15, 2023. As a major provider of medical...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $13,473.44 to Amerisourcebergen Drug Corporation for the supply of 4561889616 RESTASIS 0.05% eye emulsion in 60 single-use containers. Amerisourcebergen Drug Corporation will perform as the prime contractor, with corporate oversight provided by its parent company, Amerisourcebergen Corporation. Performance will take place in Conshohocken, Pennsylvania over a one-day period from August 21 to August 22, 2023. The...
The Defense Logistics Agency awarded a $540 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. As the prime contractor, Amerisourcebergen will supply 30 units of the ophthalmic solution to support DLA's medical logistics programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three day period in early July 2023. The delivery order was issued under DLA's pharmaceuticals and medical/surgical supply...
The Defense Logistics Agency awarded a $19,737.84 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561759139 RESTASIS 0.05% eye emulsion in 60 count bottles. Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by August 10, 2023 to support the Defense Logistics Agency's medical supply needs. As the prime contractor, Amerisourcebergen Drug Corporation will perform under the...
The Defense Logistics Agency awarded a $8,500.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562093722 RESTASIS 0.05% eye emulsion in 60 count bottles. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order is scheduled to be fulfilled on September 7th through the 8th of 2023 under the parent company Amerisourcebergen Corporation's corporate office division contract vehicle. No set aside...
The Defense Logistics Agency awarded a $6,028.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a one-day period from August 8 to August 9, 2023. No subcontractors or set aside designations were identified....
The Defense Logistics Agency awarded a $63,391 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The order is for 30 units of the product, which will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 25, 2023 to support the Defense Logistics Agency's medical supply needs. Amerisourcebergen will serve as the prime contractor on the order, which was issued under an existing DLA-wide supply contract vehicle...
The Defense Logistics Agency awarded a $7,368.09 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 units of 0.05% RESTASIS eye emulsion. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is scheduled to be completed between July 27-28, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for eye medication supports the DLA's mission to provide logistics...